Patients With Psoriasis Less Likely to Be Physically Active

This article originally appeared here.
Share this content:
Patients With Psoriasis Less Likely to Be Physically Active
Patients With Psoriasis Less Likely to Be Physically Active

MONDAY, Feb. 2, 2015 (HealthDay News) -- Patients with psoriasis are less likely to engage in physical activity, especially those with more severe disease, according to a study published in the February issue of the Journal of Dermatology.

Young Kyung Do, M.D., M.P.H., Ph.D., from the Seoul National University College of Medicine in South Korea, and colleagues examined the correlation between the extent of psoriatic skin lesions and the likelihood of participating in leisure-time moderate to vigorous physical activity (MVPA). Data were collected for 6,549 respondents to the 2003 to 2006 National Health and Nutrition Examination Survey dermatology questionnaires, aged 20 to 59 years.

The researchers found that individuals with psoriasis were less likely to have engaged in leisure-time MVPA in the past 30 days compared to those without psoriasis; the correlation was not statistically significant. Among those who participated in MVPA, patients currently having few to extensive cutaneous lesions (but not those currently having little or no psoriatic patches) logged approximately 30 percent fewer metabolic equivalent task-minutes of leisure-time MVPA compared with individuals never diagnosed with psoriasis.

"Clinicians should encourage patients with psoriasis, especially those with more severe disease, to be more physically active; they should help identify and address possible psychological and physical barriers to their patients' physical activity," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Panel Has Tie Vote on New Type 1 Diabetes Drug

FDA Panel Has Tie Vote on New Type ...

Zynquista is a once-daily pill meant to help type 1 diabetes patients manage their blood glucose levels

FDA Investigating Paclitaxel-Coated Balloons, Paclitaxel-Eluting Stents

FDA Investigating Paclitaxel-Coated Balloons, Paclitaxel-Eluting Stents

Investigation triggered by meta-analysis showing possible increased mortality in PAD patients at 2 years

Frailty Could Increase Susceptibility for Dementia

Frailty Could Increase Susceptibility for Dementia

Authors say frailty should be considered in clinical care, management of Alzheimer dementia

is free, fast, and customized just for you!




Already a member?

Sign In Now »